NCT00647491View on ClinicalTrials.gov

A Study of Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

352

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

June 30, 2005

Study Completion Date

August 31, 2005

Conditions
Rheumatoid Arthritis
Interventions
BIOLOGICAL

adalimumab

20 mg sc eow

BIOLOGICAL

adalimumab

40 mg sc eow

BIOLOGICAL

adalimumab

80 mg sc eow

BIOLOGICAL

placebo

placebo sc eow

Trial Locations (25)

Unknown

Aichi

Chiba

Ehime

Fukui

Fukuoka

Gunma

Hokkaido

Hyōgo

Ibaraki

Ishikawa

Kagoshima

Kanagawa

Kyoto

Miyagi

Nagano

Nagasaki

Niigata

Okayama

Osaka

Saitama

Shizuoka

Tochigi

Tokushima

Tokyo

Toyama

Sponsors

Lead Sponsor

Abbott
All Listed Sponsors
collaborator

Eisai Limited

INDUSTRY

lead

Abbott

INDUSTRY

NCT00647491 - A Study of Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter